Hims & Hers rolls out Peptides+ specialty for compounded peptides following HHS policy

Hims & Hers is rolling out a new Peptides+ specialty for compounded peptides and related compounds, following the HHS enforcement discretion policy issued yesterday. The initial lineup includes Sermorelin, Glutathione, Vitamin B12, NAD+ and L-carnitine.

Detected & updated continuously · Source: Nebula

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula